Aldeyra Therapeutics, Inc. Share Price
NASDAQ: ALDX | Micro CapAldeyra Therapeutics, Inc. Stock Performance
Aldeyra Therapeutics, Inc. Share Price Today
As of 9 October 2026, Aldeyra Therapeutics, Inc.'s share price is $0.95. The stock opened at $0.95, compared to its previous close of $0.95. During today's trading session, Aldeyra Therapeutics, Inc.'s share price traded between $0.92 and $0.97, with an average price of $0.94. Over the past 52 weeks, the stock has recorded a high of $5.89 and a low of $0.86. In terms of performance, Aldeyra Therapeutics, Inc.'s share price has declined by 37.78% over the last six months and is down 81.36% on a year-on-year basis.
Aldeyra Therapeutics, Inc. Share Price Chart
Aldeyra Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Aldeyra Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Aldeyra Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.22 | $0.94 | -23.33% |
Sep 2026 | $1.47 | $1.23 | -20.65% |
Aug 2026 | $1.50 | $1.55 | +0.65% |
Jul 2026 | $2.16 | $1.54 | -28.04% |
Jun 2026 | $1.73 | $2.14 | +22.99% |
May 2026 | $1.52 | $1.74 | +14.47% |
Apr 2026 | $1.75 | $1.52 | -10.59% |
Mar 2026 | $5.52 | $1.70 | -68.92% |
Feb 2026 | $5.34 | $5.47 | +2.05% |
Jan 2026 | $5.08 | $5.36 | +3.47% |
Dec 2025 | $5.39 | $5.18 | -5.56% |
Nov 2025 | $5.12 | $5.49 | +8.08% |